Ann: June 2020 Quarterly Update and Appendix 4C, page-22

I totally agree with you. I had 700k shares and I sold all of them in the past few weeks. I still believe PTX100 and 200 had good clinical outcomes so far and think all these CAR-T stuffs are just bla bla, especially now that they want to use this platform for Covid-19 treatment. I am a scientist myself and do reach in cancer. I personally thought using CAR-T platform to eliminate covid 19 virus is ridiculous. Even if it works how much is the cost for each treatment? A lot I would guess, and by the time that they developed any products, we have vaccines, few dollars per shot. It looks like the company is desperate and I have started to think they don’t have any good developments in PTX100 and 200 fronts. This is of course my thoughts.